infliximab

An immunosuppressive drug (trademark Remicade) administered by intravenous injection especially to treat the symptoms of Crohn's disease, ulcerative colitis, and rheumatoid arthritis. It is a chimeric monoclonal antibody prepared from humans and mice that acts by binding to and blocking the activity of tumor necrosis factor.